Kolon TissueGene (950160) closed higher on the KOSDAQ market on the 4th, ahead of the weekend, recovering the 17,000-won closing level.

The stock finished the day at 17,100 won, up 190 won (1.12%) from the previous trading day. On the 3rd, it plunged more than 5%, pushing its closing price below the 17,000-won level, but it succeeded in rebounding within a day, climbing back into the 17,000-won range.

The overall strength of the market also appears to have supported investor sentiment. On the same day, the KOSDAQ index closed at 813.50, up 23.29 points (2.95%) from the previous trading day. However, Kolon TissueGene's gain on the day fell short of the KOSDAQ index's rise.

As the stock has not yet fully recovered the losses from the 3rd, market attention is focused on whether it can continue its rebound after the weekend.

According to regulatory filings, Kolon TissueGene is a company engaged in new drug development using the cell gene technology TG-C Platform.

[※ This article is for investment reference purposes only; investment decisions and responsibilities lie with the investor.]